Related Experiment Video
Updated: Dec 9, 2025

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
The Brain Microenvironment Induces DNMT1 Suppression and Indolence of Metastatic Cancer Cells
Eishu Hirata1,2, Kojiro Ishibashi1, Shinji Kohsaka3
1Division of Tumor Cell Biology and Bioimaging, Cancer Research Institute of Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.
Abstract:
Brain metastasis is an ineffective process, and many cancer cells enter into an indolent state following extravasation in the brain. Single cell RNA sequencing of melanoma brain metastases reveals that non-proliferating brain metastatic melanoma cells exhibit a pattern of gene expression associated with inhibition of DNA methyltransferase 1 (DNMT1). The brain microenvironment, specifically the combination of reactive astrocytes and mechanically soft surroundings, suppressed DNMT1 expression in various cancer types and caused cell cycle delay. Somewhat unexpectedly, we find that DNMT1 suppression not only induces cell cycle delay but also activates pro-survival signals in brain metastatic cancer cells, including L1CAM and CRYAB. Our results demonstrate that transcriptional changes triggered by DNMT1 suppression is a key step for cancer cells to survive in the brain microenvironment and that they also restrict cancer cell proliferation. The dual consequences of DNMT1 suppression can explain the persistence of indolent cancer cells in the brain microenvironment.
Insights
Cancer cells in the brain survive by downregulating DNA methyltransferase 1 (DNMT1), which halts proliferation and activates survival pathways. This explains why indolent cancer cells persist in the brain microenvironment.
Area of Science:
- Oncology
- Molecular Biology
- Neuroscience
Background:
- Brain metastasis is a complex process where cancer cells often enter an indolent state after reaching the brain.
- Non-proliferating melanoma cells in brain metastases show gene expression linked to DNA methyltransferase 1 (DNMT1) inhibition.
Purpose of the Study:
- To investigate the role of DNMT1 inhibition in cancer cell adaptation and survival within the brain microenvironment.
- To understand the molecular mechanisms underlying the persistence of indolent cancer cells in the brain.
Main Methods:
- Single-cell RNA sequencing of melanoma brain metastases.
- Analysis of gene expression patterns in non-proliferating cancer cells.
- Investigating the impact of the brain microenvironment (reactive astrocytes, soft mechanics) on DNMT1 expression.
Main Results:
- DNMT1 suppression was observed in non-proliferating melanoma brain metastases.
- The brain microenvironment, including astrocytes and soft surroundings, suppresses DNMT1 and delays cell cycle.
- DNMT1 suppression activates pro-survival genes (e.g., L1CAM, CRYAB) and restricts proliferation.
Conclusions:
- DNMT1 suppression is a critical adaptation for cancer cell survival in the brain.
- Transcriptional changes due to DNMT1 inhibition facilitate cancer cell persistence and dormancy.
- The dual effect of DNMT1 suppression (survival and proliferation restriction) explains indolent cancer cell presence in the brain.
Related Concept Videos
The Tumor Microenvironment
MicroRNAs
MicroRNAs
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

